Filing Details

Accession Number:
0001181431-13-002834
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-01-10 16:35:43
Reporting Period:
2013-01-08
Filing Date:
2013-01-10
Accepted Time:
2013-01-10 16:35:43
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1016169 Antares Pharma Inc. ATRS Surgical & Medical Instruments & Apparatus (3841) 411350192
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1054942 F Robert Apple C/O Antares Pharma, Inc.
100 Princeton South, Suite 300
Ewing NJ 08628
Executive Vice President & Cfo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-01-08 25,000 $0.47 335,270 No 4 M Direct
Common Stock Disposition 2013-01-08 25,000 $4.01 310,270 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock STOCK OPTION (RIGHT TO BUY) Disposition 2013-01-08 25,000 $0.00 25,000 $0.47
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
1,211,158 2018-11-12 No 4 M Direct
Footnotes
  1. The stock option exercises and sales of common stock reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
  2. The options vested in equal quarterly installments over three years following the grant date.